AN UNBIASED VIEW OF TEMAZEPAM

Coadministration with CYP3A4 substrates, notably People having a slim therapeutic index, can lead to diminished concentrations and lack of efficacy. If not able to stay clear of coadministration, monitor CYP3A4 substrate amounts and change dose as desired.bremelanotide will reduce the extent or impact of triazolam by Other (see comment). Steer clea